187 related articles for article (PubMed ID: 32468289)
1. Construction and evaluation of an antibody phage display library targeting heparan sulfate.
Damen LAA; van de Westerlo EMA; Versteeg EMM; van Wessel T; Daamen WF; van Kuppevelt TH
Glycoconj J; 2020 Aug; 37(4):445-455. PubMed ID: 32468289
[TBL] [Abstract][Full Text] [Related]
2. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney.
van Kuppevelt TH; Dennissen MA; van Venrooij WJ; Hoet RM; Veerkamp JH
J Biol Chem; 1998 May; 273(21):12960-6. PubMed ID: 9582329
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of heparan sulfates in human lung.
Smits NC; Robbesom AA; Versteeg EM; van de Westerlo EM; Dekhuijzen PN; van Kuppevelt TH
Am J Respir Cell Mol Biol; 2004 Feb; 30(2):166-73. PubMed ID: 12896874
[TBL] [Abstract][Full Text] [Related]
4. Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n.
ten Dam GB; van de Westerlo EM; Smetsers TF; Willemse M; van Muijen GN; Merry CL; Gallagher JT; Kim YS; van Kuppevelt TH
J Biol Chem; 2004 Sep; 279(37):38346-52. PubMed ID: 15247295
[TBL] [Abstract][Full Text] [Related]
5. Isolation of Antibodies to Heparan Sulfate on Glypicans by Phage Display.
Kim H; Ho M
Curr Protoc Protein Sci; 2018 Nov; 94(1):e66. PubMed ID: 30091851
[TBL] [Abstract][Full Text] [Related]
6. Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies.
Dennissen MA; Jenniskens GJ; Pieffers M; Versteeg EM; Petitou M; Veerkamp JH; van Kuppevelt TH
J Biol Chem; 2002 Mar; 277(13):10982-6. PubMed ID: 11790764
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.
Thompson SM; Fernig DG; Jesudason EC; Losty PD; van de Westerlo EM; van Kuppevelt TH; Turnbull JE
J Biol Chem; 2009 Dec; 284(51):35621-31. PubMed ID: 19837661
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding.
Solari V; Rudd TR; Guimond SE; Powell AK; Turnbull JE; Yates EA
Org Biomol Chem; 2015 Jun; 13(21):6066-72. PubMed ID: 25952831
[TBL] [Abstract][Full Text] [Related]
9. N-Acetylated domains in heparan sulfates revealed by a monoclonal antibody against the Escherichia coli K5 capsular polysaccharide. Distribution of the cognate epitope in normal human kidney and transplant kidney with chronic vascular rejection.
Born J; Jann K; Assmann KJ; Lindahl U; Berden JH
J Biol Chem; 1996 Sep; 271(37):22802-9. PubMed ID: 8798457
[TBL] [Abstract][Full Text] [Related]
10. Detection and characterization of syndecan-1-associated heparan sulfate 6-O-sulfated motifs overexpressed in multiple myeloma cells using single chain antibody variable fragments.
Delcommenne M; Klingemann HG
Hum Antibodies; 2012; 21(1-2):29-40. PubMed ID: 22885958
[TBL] [Abstract][Full Text] [Related]
11. A mutant-cell library for systematic analysis of heparan sulfate structure-function relationships.
Qiu H; Shi S; Yue J; Xin M; Nairn AV; Lin L; Liu X; Li G; Archer-Hartmann SA; Dela Rosa M; Galizzi M; Wang S; Zhang F; Azadi P; van Kuppevelt TH; Cardoso WV; Kimata K; Ai X; Moremen KW; Esko JD; Linhardt RJ; Wang L
Nat Methods; 2018 Nov; 15(11):889-899. PubMed ID: 30377379
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.
Jenniskens GJ; Oosterhof A; Brandwijk R; Veerkamp JH; van Kuppevelt TH
J Neurosci; 2000 Jun; 20(11):4099-111. PubMed ID: 10818145
[TBL] [Abstract][Full Text] [Related]
13. Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.
Kurup S; Wijnhoven TJ; Jenniskens GJ; Kimata K; Habuchi H; Li JP; Lindahl U; van Kuppevelt TH; Spillmann D
J Biol Chem; 2007 Jul; 282(29):21032-42. PubMed ID: 17517889
[TBL] [Abstract][Full Text] [Related]
14. Phage display mapping for peptide 11 sensitive sequences binding to laminin-1.
Kazmin DA; Hoyt TR; Taubner L; Teintze M; Starkey JR
J Mol Biol; 2000 May; 298(3):431-45. PubMed ID: 10772861
[TBL] [Abstract][Full Text] [Related]
15. 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.
Ten Dam GB; Kurup S; van de Westerlo EM; Versteeg EM; Lindahl U; Spillmann D; van Kuppevelt TH
J Biol Chem; 2006 Feb; 281(8):4654-62. PubMed ID: 16373349
[TBL] [Abstract][Full Text] [Related]
16. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
[TBL] [Abstract][Full Text] [Related]
17. Phage display-derived human antibodies against specific glycosaminoglycan epitopes.
Smits NC; Lensen JF; Wijnhoven TJ; Ten Dam GB; Jenniskens GJ; van Kuppevelt TH
Methods Enzymol; 2006; 416():61-87. PubMed ID: 17113860
[TBL] [Abstract][Full Text] [Related]
18. Novel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung.
Thompson SM; Connell MG; Fernig DG; Ten Dam GB; van Kuppevelt TH; Turnbull JE; Jesudason EC; Losty PD
Pediatr Surg Int; 2007 May; 23(5):411-7. PubMed ID: 17216534
[TBL] [Abstract][Full Text] [Related]
19. Use of a phage display antibody to measure the enzymatic activity of the Sulfs.
Uchimura K; Lemjabbar-Alaoui H; van Kuppevelt TH; Rosen SD
Methods Enzymol; 2010; 480():51-64. PubMed ID: 20816204
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes.
Shibata S; Sasaki T; Harpel P; Fillit H
Clin Immunol Immunopathol; 1994 Feb; 70(2):114-23. PubMed ID: 8299226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
